MAP3K3 and ovarian serous carcinoma: Our previous study19 found that the mutation rate of KRAS in serous ovarian carcinoma was only 8.6%, so the mutation of RAS gene also caused the overexpression of MAP3K3 in some ovarian carcinomas.